<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="106">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05159765</url>
  </required_header>
  <id_info>
    <org_study_id>VTI-NVMF-MPC-RCT-001</org_study_id>
    <nct_id>NCT05159765</nct_id>
  </id_info>
  <brief_title>Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial</brief_title>
  <acronym>PROTECT</acronym>
  <official_title>Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Visioneering Technologies, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Visioneering Technologies, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, randomized, double-masked clinical trial. All study devices are&#xD;
      market approved/cleared in the localities where the study is conducted. Subjects will be&#xD;
      randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue&#xD;
      Multifocal (NVMF) soft contact lenses for a total of three years.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">August 2025</completion_date>
  <primary_completion_date type="Anticipated">August 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Refractive Error relative to Baseline</measure>
    <time_frame>Baseline, 12, 24, 36 months</time_frame>
    <description>Mean change in cycloplegic auto-refraction (D)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Axial Length</measure>
    <time_frame>Baseline,12, 24, 36 months</time_frame>
    <description>Mean change in Axial Length (mm)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Myopia, Progressive</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Contact lens with refractive correction, single vision optic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Contact lens with refractive correction, multifocal optic</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single vision contact lenses</intervention_name>
    <description>Wearing contact lenses during waking hours may alter the progression of myopia</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multifocal contact lenses</intervention_name>
    <description>Wearing contact lenses during waking hours may alter the progression of myopia</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female, aged 7 to &lt;13 (inclusive) at the Screening/Baseline examination.&#xD;
&#xD;
          2. Meet the following refractive criteria determined by cycloplegic autorefraction at&#xD;
             Screening/Baseline:&#xD;
&#xD;
               -  Spherical Equivalent Refractive Error (SERE): between -0.75 and -5.00 D&#xD;
                  inclusive.&#xD;
&#xD;
               -  Astigmatism: â‰¤ -0.75 D&#xD;
&#xD;
               -  Anisometropia: &lt; 1.000&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Has previously worn or currently wears rigid or gas permeable contact lenses,&#xD;
             including orthokeratology lenses,&#xD;
&#xD;
          2. Appears to exhibit poor personal hygiene, that, in the Investigator's opinion, might&#xD;
             prevent safe contact lens wear.&#xD;
&#xD;
          3. Is currently, or within 30 days prior to this study has been, an active participant in&#xD;
             another clinical study.&#xD;
&#xD;
          4. Current or prior use of bifocals, progressive addition lenses, atropine, pirenzepine,&#xD;
             multifocal or specialized contact lenses, or ANY other myopia control treatment.&#xD;
&#xD;
          5. The Investigator for any reason considers that it is not in the best interest of the&#xD;
             subject to participate in the study, including if the child is not mature enough to&#xD;
             independently handle and care for soft contact lenses.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashley Tuan, OD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>VTI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ashley Tuan, OD, PhD</last_name>
    <phone>1-844-884-5367</phone>
    <phone_ext>102</phone_ext>
    <email>atuan@vtivision.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ashley Tuan, OD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto Eye Care</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4W 1A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Caffery, OD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 2, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>myopia, refractive errors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Myopia, Degenerative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

